Who are Jazz Pharmaceuticals plc's main suppliers?

Jazz Pharmaceuticals plc (JAZZ) key suppliers include: Werewolf Therapeutics, Inc., SIMTRA, Zymeworks Inc.. View the full supplier network at chainsifter.com/chain/JAZZ.

Who are Jazz Pharmaceuticals plc's major customers?

Jazz Pharmaceuticals plc (JAZZ) key customers include: ESSDS, McKesson Corporation, McKesson Corporation, Axsome Therapeutics, Inc., Werewolf Therapeutics, Inc. and 3 more. View the full customer network at chainsifter.com/chain/JAZZ.

What sector is Jazz Pharmaceuticals plc in?

Jazz Pharmaceuticals plc (JAZZ) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

JAZZ Supply Chain: Jazz Pharmaceuticals plc Supplier List & 13 Relationships

3Suppliers

8Customers

2Debt Items

20Related Chains

Jazz Pharmaceuticals plc Suppliers

Ticker	Name	Confidence	Evidence
HOWL	Werewolf Therapeutics, Inc.	90%	Reciprocal relationship from HOWL graph: Jazz acquired exclusive global development and commercialization rights to WTX-613, which has subsequently been designated JZP898, as well as products contain…
SIMTRA	SIMTRA	90%	Vyxeos is manufactured by Simtra, which is a sole source supplier from a single site location.
ZYME	Zymeworks Inc.	85%	Reciprocal relationship from ZYME graph: Reciprocal relationship from JAZZ graph: Reciprocal relationship from ZYME graph: : $ , 2022: $ ) in research and development expense and general and administ…

Jazz Pharmaceuticals plc Customers

Ticker	Name	Confidence	Evidence
ESSDS	ESSDS	92%	The following table presents a summary of the percentage of total revenues from customers that represented more than 10% of our total revenues: Three Months Ended March 31, 2026 2025 ESSDS 41 % 42 %
MCK	McKesson Corporation	92%	The following table presents a summary of the percentage of total revenues from customers that represented more than 10% of our total revenues: Three Months Ended March 31, 2026 2025 McKesson 12 % 11 %
MCK	McKesson Corporation	92%	Reciprocal relationship from MCK graph: Reciprocal relationship from JAZZ graph: The following table presents a summary of the percentage of total revenues from customers that represented more than 1…
AXSM	Axsome Therapeutics, Inc.	90%	Reciprocal relationship from AXSM graph: Pursuant to the Purchase Agreement, the Company agreed to make non-refundable, non-creditable royalty payments to Jazz
HOWL	Werewolf Therapeutics, Inc.	90%	Reciprocal relationship from HOWL graph: Jazz generally reimbursed us for the cost of such activities.
CARDINAL	CARDINAL	85%	Zepzelca, Rylaze, Vyxeos and Ziihera are sold to customers through subsidiary specialty distributors of McKesson, Cencora, and Cardinal
CENCORA	CENCORA	85%	Zepzelca, Rylaze, Vyxeos and Ziihera are sold to customers through subsidiary specialty distributors of McKesson, Cencora, and Cardinal
VOR	Vor Biopharma Inc.	72%	Reciprocal relationship from VOR graph: Vanflyta (quizartinib), Jazz Pharmaceuticals plc’s Vyxeos (daunorubicin and cytarabine), Novartis International AG’s Rydapt (midostaurin), Pfizer Inc.’s Mylota…

Jazz Pharmaceuticals plc Debt Obligations

Instrument	Description	Confidence	Evidence
JAZZ-DEBT-10419	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.
JAZZ-DEBT	Debt stack $5.4B	90%	Market cache reports total debt of $5.4B.

Jazz Pharmaceuticals plc Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Jazz Pharmaceuticals plc.

Jazz Pharmaceuticals plc Ownership

Holder	Name	Confidence	Evidence
JAZZ-OWNER-BLACKROCK-INC	BlackRock, Inc.	90%	13F overlay lists BlackRock, Inc. as top holder; 579 tracked holders.

Jazz Pharmaceuticals plc Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
BMY	Bristol-Myers Squibb Company	100.00	2
EVAX	Evaxion A/S	100.00	2
CAH	Cardinal Health, Inc.	100.00	2
CLH	Clean Harbors, Inc.	100.00	2
CUE	Cue Biopharma, Inc.	100.00	2
ARDX	Ardelyx, Inc.	100.00	2
DYN	Dyne Therapeutics, Inc.	100.00	2
ADAG	Adagene Inc.	100.00	2
IMMP	Immutep Limited	100.00	2
CPMV	Mosaic ImmunoEngineering, Inc.	100.00	2
EMMA	Emmaus Life Sciences, Inc.	100.00	2
CTMX	CytomX Therapeutics, Inc.	100.00	2
PSNL	Personalis, Inc.	100.00	2
BNBX	BNB Plus Corp.	100.00	2
EDSA	Edesa Biotech, Inc.	100.00	2
CVS	CVS Health Corporation	100.00	2
REGN	Regeneron Pharmaceuticals, Inc.	100.00	2
SDGR	Schrödinger, Inc.	100.00	2
CHRS	Coherus Oncology, Inc.	100.00	2
HLNCF	Haleon plc	100.00	2

Jazz Pharmaceuticals plc Supply Chain